| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2008 | EP1530464B1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 07/09/2008 | EP1525188B1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same |
| 07/09/2008 | EP1523571B1 Sgk and nedd used as diagnostic and therapeutic targets |
| 07/09/2008 | EP1509221B1 N-acylaminoacetonitrile derivatives and their use for controlling parasites |
| 07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 07/09/2008 | EP1469858B1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/09/2008 | EP1465863B1 Potassium channel modulators |
| 07/09/2008 | EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 07/09/2008 | EP1448220B1 Pharmaceutical composition comprising an antiphlogistic agent and lactalbuminhydrolysate and the use thereof |
| 07/09/2008 | EP1446144B1 The use of leptin in infertility |
| 07/09/2008 | EP1427391B1 Solid-phase agent for vascular occlusion with immobilised platelet binding agent |
| 07/09/2008 | EP1411780B1 Soluble roasted chicory with high inulin content |
| 07/09/2008 | EP1399424B1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/09/2008 | EP1392348B1 Treatment of dementia and neurodegenerative diseases with intermediate doses of lhrh antagonists |
| 07/09/2008 | EP1390367B1 DIHYDROIMIDAZO 5,1-A -$G(b)-CARBOLINE DERIVATIVES, METHOD FOR PREPARING SAME AND USE THEREOF AS MEDICINE |
| 07/09/2008 | EP1390008B1 Pharmaceutical and cosmetic compositions comprising phospholipid complexes of vitis vinifera and of centella asiactica |
| 07/09/2008 | EP1385499B1 Use of carnitine for the preparation of an injection solution for preventing or alleviating ascites in poultry by in-ovo injection |
| 07/09/2008 | EP1379496B1 Sulphones which modulate the action of gamma secretase |
| 07/09/2008 | EP1379251B1 Inhibitors of akt activity |
| 07/09/2008 | EP1372383B1 A product comprising a susbtrate and an antimicrobial formulation |
| 07/09/2008 | EP1370243B1 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 07/09/2008 | EP1303304B1 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 07/09/2008 | EP1286674B1 Composition for potentiating cancer chemotherapeutic agents |
| 07/09/2008 | EP1276729B1 New neurokinin antagonists for use as medicaments |
| 07/09/2008 | EP1226177B1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/09/2008 | EP1220842B1 Cyclic amine compound as ccr5 antagonist |
| 07/09/2008 | EP1219624B1 Remedies for neuropathic pain and model animals of neuropathic pain |
| 07/09/2008 | EP1207891B1 Use of a low molecular weight sulphated polysaccharide in the treatment of thrombosis |
| 07/09/2008 | EP1058680B1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 07/09/2008 | EP0984969B1 Fused dihydropyrans |
| 07/09/2008 | EP0968712B1 Felbinac-containing patch |
| 07/09/2008 | EP0959878B1 Method for treating renal failure |
| 07/09/2008 | EP0871451B2 Composition comprising plant stanol esters and the use thereof for lowering the serum cholesterol |
| 07/09/2008 | EP0734260B2 Paroxetine tablets and process to prepare them |
| 07/09/2008 | EP0620828B2 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 07/09/2008 | CN101218340A Polysaccharide produced by microorganism belonging to genus bifidobacterium |
| 07/09/2008 | CN101218246A Improved crystalline form of compound A-348441 |
| 07/09/2008 | CN101218245A 3-ester prodrugs of ethynylestradiol |
| 07/09/2008 | CN101218241A Pyrrolopyridine derivatives as protein kinase inhibitors |
| 07/09/2008 | CN101218240A Process for preparing bicyclic compounds |
| 07/09/2008 | CN101218238A Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 07/09/2008 | CN101218236A 2-heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 07/09/2008 | CN101218235A Bicyclic derivatives as modulators of ion channels |
| 07/09/2008 | CN101218234A Phenyl-3-{(3-(1H-pyrrol-2-yl)-[1,2,4]oxadiazol-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218233A PPARalpha/gamma agonists and processes of preparing |
| 07/09/2008 | CN101218232A Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218231A Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 07/09/2008 | CN101218230A Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 07/09/2008 | CN101218229A Pyrazolyl-amino-substituted pyrimidines and their use in the treatment of cancer |
| 07/09/2008 | CN101218228A Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts |
| 07/09/2008 | CN101218227A Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 07/09/2008 | CN101218226A Bicyclic derivatives as modulators of ion channels |
| 07/09/2008 | CN101218224A Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/09/2008 | CN101218223A Benzodioxane and benzodioxolane derivatives and uses thereof |
| 07/09/2008 | CN101218220A Choline salt crystal of azulene compound |
| 07/09/2008 | CN101218217A Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 07/09/2008 | CN101218211A Quinoxaline derivatives as antitumor agents |
| 07/09/2008 | CN101218209A Benzimidazole derivatives for treatment of inflammatory diseases |
| 07/09/2008 | CN101218207A Cathepsin cysteine protease inhibitors |
| 07/09/2008 | CN101218204A Modified poly(propylene-imine) dendrimers and their use as transfection agents for anionic bioactive factors |
| 07/09/2008 | CN101218203A Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the ss2 adrenergic receptor |
| 07/09/2008 | CN101218201A Benzoic acid derivatives that are modulators or antagonists of GlyR |
| 07/09/2008 | CN101218199A New compounds i |
| 07/09/2008 | CN101217982A Drug-containing photocrosslinked hyaluronic acid derivative gel |
| 07/09/2008 | CN101217980A New combination of anti-MADCAM antibody and antifibrotic caspase inhibitor to treat liver fibrosis |
| 07/09/2008 | CN101217972A Method for fostering bone formation and preservation |
| 07/09/2008 | CN101217967A Novel use of enantiomer |
| 07/09/2008 | CN101217966A Combination therapy of cancer with AZD2171 and gemcitabine |
| 07/09/2008 | CN101217965A Glucose uptake modulator and method for treating diabetes or diabetic complications |
| 07/09/2008 | CN101217964A Method for preparing and using water-based steroid pheromone compositions |
| 07/09/2008 | CN101217963A Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 07/09/2008 | CN101217962A Therapeutic agents targeting the NCCa-ATP channel and methods of use thereof |
| 07/09/2008 | CN101217961A Uses of prostacyclin analogs |
| 07/09/2008 | CN101217960A Therapeutic agent and treatment method for ameliorating uremia |
| 07/09/2008 | CN101217959A Eslicarbazepine acetate and methods of use |
| 07/09/2008 | CN101217958A Inhibitors of AKT activity |
| 07/09/2008 | CN101217957A 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2 |
| 07/09/2008 | CN101217956A Compositions and methods for treatment for neoplasms |
| 07/09/2008 | CN101217955A Bicyclic 6-alkylidene-penems as class-D beta-lactamases inhibitors |
| 07/09/2008 | CN101217954A Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 07/09/2008 | CN101217953A Compounds having immunomodulator activity |
| 07/09/2008 | CN101217952A Composition for preventing occurrence of cardiovascular event |
| 07/09/2008 | CN101217951A Formulations containing fenofibrate and a surfactant mixture |
| 07/09/2008 | CN101217950A Improved formulations of fenofibrate containing menthol or a PEG/poloxamer mixture |
| 07/09/2008 | CN101217949A 治疗睡眠-清醒病症 Treatment of sleep - wake disorders |
| 07/09/2008 | CN101217946A Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostics and therapy |
| 07/09/2008 | CN101217944A Pharmaceutical formulations comprising fenofibric acid and/or its salts |
| 07/09/2008 | CN101217943A Prolonged release formulation of active principles |
| 07/09/2008 | CN101217936A Pharmaceutical formulation of apomorphine for buccal administration |
| 07/09/2008 | CN101217874A Method of treating or preventing bone deterioration or osteoporosis |
| 07/09/2008 | CN101217870A Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
| 07/09/2008 | CN101215601A Effectors of innate immunity determination |
| 07/09/2008 | CN101215544A Inflammation-inhibiting compounds |
| 07/09/2008 | CN101215336A Method for purifying medicinal plant polysaccharide |
| 07/09/2008 | CN101215313A Marsdenia tenacissima carbon-21 steroid saponin mixture with antineoplastic effect |
| 07/09/2008 | CN101215305A Glucosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 07/09/2008 | CN101215304A Lactosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |
| 07/09/2008 | CN101215303A Xylosyl thiourea heterocyclic compound and its synthetic method and application in antineoplastic |